Patent · US Active

Colon cleansing compositions

US7658914B2 · kind B2 · utility

16Cited by
9References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2006
Grant dateFeb 9, 2010
Priority date
Expiry dateDec 8, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition comprising, per liter of aqueous solution, from 30 to 350 g polyethylene glycol, from 3 to 20 g of an ascorbic acid component selected form the group consisting of ascorbic acid, a salt of ascorbic acid, or a mixture thereof, an alkali metal or alkaline earth metal sulphate, preferably from 1 to 15 g thereof, and optionally one or more electrolytes selected from sodium chloride, potassium chloride, and sodium hydrogen carbonate, and preferably also comprising flavorings, is effective in cleansing the gut in preparation for a endoscopy, especially colonoscopy. It is safer than conventional sodium phosphate-based gut cleansing compositions, and hence can be used for patients who would be at risk with sodium phosphate-based compositions, and is better tolerated than conventional PEG-based compositions, leading to better patient compliance and enabling effective out-patient use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.